Article
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration.
JAMA cardiology - 1 May 2025
Porcari Aldostefano, Razvi Yousuf, Cappelli Francesco, Nitsche Christian, Serenelli Matteo, Longhi Simone, Sinigiani Giulio, Cipriani Alberto, Aimo Alberto, Tomasoni Daniela, Zampieri Mattia, Cantone Anna, Allegro Valentina, Vergaro Giuseppe, Masri Ahmad, Urey Marcus, Ioannou Adam, Petrie Aviva, Noory Navid, Gustafsson Finn, Poledniczek Michael, Emdin Michele, Metra Marco, Sinagra Gianfranco, Martinez-Naharro Ana, Wechalekar Ashutosh D, Lachman Helen, Whelan Carol, Hawkins Philip N, Solomon Scott D, Gillmore Julian D, Fontana Marianna
Abstract excerpt
Importance: Patients with transthyretin (ATTR) cardiac amyloid infiltration are increasingly diagnosed at earlier disease stages with no heart failure (HF) symptoms and a wide range of cardiac amyloid infiltration. Objective: To characterize the clinical phenotype and natural history of asymptomatic patients with ATTR cardiac amyloid infiltration. Design, Setting, and Participants: This cohort study analyzed data...
Read the complete abstract on PubMedTopics
- Humans
- Male
- Female